Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC

Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC Mon, 4 Oct 2004 An Op Ed article in The Washington Post by Shannon Brownlee (below) nails the elite procurers of psychotropic drugs who have long denied the ominous signals . . . Continue reading →

When Doctors Go to Class, Industry Often Foots the Bill – WSJ

When Doctors Go to Class, Industry Often Foots the Bill – WSJ Fri, 6 Dec 2002 A front page article in The Wall Street Journal by Scott Hensley sheds further light on the corruption of medical ethics by focusing on a drug . . . Continue reading →

Harvard / Stanford–Psychiatrists’ Financial Ties to Industry

Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies. Continue reading →

NEJM Vioxx Safety Correction / Consumers International Accuses Industry–Unscrupulous Marketing

Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Continue reading →

Doctors Back Ban on Gifts From Drug Makers_Journal Hypocrisy

"32% of the advertisements [in peer reviewed journals] misled readers regarding efficacy, 40% did not provide balanced descriptions of the side effects, and 44% could lead to improper prescribing if the physician did not use other sources of information regarding the drug." Continue reading →